<DOC>
	<DOCNO>NCT00455702</DOCNO>
	<brief_summary>The study aim assess effect single dose repeated weekly dose 50mg d-cycloserine versus placebo cognitive memory function schizophrenia patient . The study also examine effect 50mg d-cycloserine positive symptom negative symptom , well assess tolerability side-effects .</brief_summary>
	<brief_title>Effects Weekly Dosing D-cycloserine Cognitive Function Individuals With Schizophrenia</brief_title>
	<detailed_description>This ten-week , parallel-group , placebo-controlled trial examine cognitive effect week 1 , 2 , 3 . 4 , 5 , 6 , 7 , 8 &amp; 10 once-weekly oral D-cycloserine 50 mg add stable dose antipsychotic 8 week 60 adult outpatient schizophrenia . Specific aim : 1 . Assess effect single dose D-cycloserine 50 mg cognitive functioning compare placebo . 2 . Assess effect repeat weekly dose D-cycloserine cognitive functioning week 8 compare placebo . 3 . Assess effect repeat weekly dose D-cycloserine memory function week 1 hour medication administration compare placebo . 4 . Assess persistence learn information no-treatment follow-up assessment Week 10 D-cycloserine group compare placebo group . 5 . Assess effect weekly D-cycloserine dosing positive &amp; negative symptom week 8 compare placebo . 6 . Assess tolerability side effect weekly D-cycloserine compare placebo . 7 . Assess effect d-cycloserine dosed weekly seven week reward responsiveness measure response bias task compare placebo . 8 . Assess effect d-cycloserine dosed weekly seven week measure function .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>1 . Male female 2 . Age 1865 year 3 . Diagnosis schizophrenia schizoaffective disorder , depress type 4 . Stable dose antipsychotic least 4 week . 5 . Able provide inform consent 6 . Able complete cognitive battery 1 . Current treatment clozapine 2 . Dementia 3 . Seizure disorder 4 . Unstable medical illness 5 . Active substance abuse 6 . Pregnancy , nursing , unwilling use appropriate birth control measure participation female fertile .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>cognition</keyword>
	<keyword>d-cycloserine</keyword>
	<keyword>memory</keyword>
</DOC>